Similarly, a study by Niu et al. demonstrated that elevated RUNX2 levels in thyroid carcinoma induce the expression of vasculogenic factors VEGFA and VEGFC, thus promoting tumor invasiveness [148]. Here, RUNX2 is linked to neoplasm.